The bone biopsy protocol for evaluating osteoporosis and osteomalacia.
Although this paper has dealt with well-established diagnostic procedures, I have attempted to present a practical summary based on experience with over 400 cases. A complete and modern approach to the evaluation of the bone biopsy for metabolic bone disease may be summarized as follows: Preoperative double labeling with tetracycline (two 3-day courses of tetracycline separated by 12 days); Full-thickness iliac bone biopsy yielding a 5- to 6-mm diameter specimen; Undecalcified sectioning (5-10 mu) processed in glycol or methyl methacrylate; Histomorphometric analysis with light microscope and planimeter; Tetracycline analysis with fluorescent microscope.
D001706:Biopsy; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology*; D006652:Histological Techniques; D006801:Humans; D008856:Microscopy, Fluorescence; D008903:Minerals / Q000378:metabolism; D010010:Osteoclasts / Q000473:pathology; D010018:Osteomalacia / Q000473:pathology*; D010024:Osteoporosis / Q000473:pathology*; D013752:Tetracycline
D008903:Minerals; D013752:Tetracycline